Company:

Aspen Neuroscience

Management:

Damiem Mcdevit

Designation:

President & CEO

Headquarters:

San Diego, CA

Website:

aspenneuroscience.com

Aspen Neuroscience is a clinical stage regenerative medicine biotechnology company focused on developing autologous induced pluripotent stem cell derived therapies, beginning with Parkinson’s disease. Its lead investigational therapy, sasineprocel (ANPD001), aims to replace lost dopaminergic neurons and restore neural function. The company is dedicated to advancing personalized regenerative treatments that offer new hope for individuals living with Parkinson’s disease

Company:

Auragens

Management:

Dr. Daniel S. Briggs

Designation:

President & CEO

Headquarters:

Panama City, PA

Website:

auragens.com

Auragens is a regenerative medicine company specializing in advanced stem cell therapies and personalized treatment solutions. Based in Panama, the organization focuses on helping patients manage chronic, degenerative, and age related conditions through innovative regenerative approaches. With a multidisciplinary team and modern treatment facilities, Auragens aims to enhance patient outcomes, improve quality of life, and support long term wellness.

Company:

BioXcellerator

Management:

Eric Stoffers

Designation:

CEO

Headquarters:

Scottsdale, AZ

Website:

bioxcellerator.com

BioXcellerator is a global leader in stem cell therapy and research, focused on improving health, immunity, longevity, and overall quality of life. The organization helps individuals suffering from autoimmune and degenerative diseases through advanced stem cell treatments. Supported by a team of scientists, physicians, and researchers, BioXcellerator continues to drive innovation and advancements in regenerative medicine.

Company:

Celularity

Management:

Robert J. Hariri

Designation:

Chairperson, Founder, & CEO

Headquarters:

Florham Park, NJ

Website:

celularity.com

Celularity is a clinical stage biotechnology company focused on advancing cellular medicine through off the shelf allogeneic placenta derived therapies. Headquartered in Florham Park, New Jersey, the company leverages the therapeutic potential of postpartum placental cells, including T cells, NK cells, and pluripotent stem cells, to develop innovative treatments for cancer, infectious diseases, and degenerative conditions.

Company:

DVC Stem

Management:

Louis A. Cona

Designation:

Medical Director

Headquarters:

Grand Cayman, KY

Website:

dvcstem.com

DVC Stem is a regenerative medicine provider specializing in advanced stem cell therapies for a range of medical conditions. The organization offers innovative treatment options through a state of the art facility staffed by licensed professionals and experienced physicians. Its protocols are IRB approved, and stem cells are sourced from FDA compliant laboratories, ensuring high standards of quality, safety, and patient care.

Company:

InGeneron

Management:

Eckhard Alt

Designation:

CEO

Headquarters:

Houston, TX

Website:

ingeneron.com

InGeneron is a clinical stage biotechnology company developing safe, evidence based cell therapies that utilize a patient’s own regenerative cells for same day treatment. The company focuses on minimally invasive therapies for orthopedic conditions and is conducting multiple clinical trials to validate its technology. Backed by more than 20 years of research, InGeneron is committed to advancing clinically supported regenerative treatments.

Company:

Longeveron

Management:

Stephen H. Willard

Designation:

CEO

Headquarters:

Miami, FL

Website:

longeveron.com

Longeveron is a clinical stage regenerative medicine biotechnology company focused on developing cell based therapies for chronic and aging related conditions. Its lead investigational product, laromestrocel (Lomecel-B™), is derived from mesenchymal stem cells sourced from healthy adult donors. The company is advancing clinical programs targeting Alzheimer’s disease, aging related frailty, and rare pediatric conditions while promoting healthier aging through regenerative medicine.

Company:

R3 Stem Cell

Management:

David Greene

Designation:

Founder & CEO

Headquarters:

Scottsdale, AZ

Website:

r3stemcell.com

R3 Stem Cell is a regenerative medicine company specializing in stem cell, exosome, and biologic therapies for orthopedic, musculoskeletal, and chronic health conditions. Headquartered in Scottsdale, Arizona, the company operates through a network of Centers of Excellence across multiple locations worldwide. R3 Stem Cell focuses on providing non surgical treatment options while supporting healthcare providers with regenerative medicine solutions

Company:

RMI

Management:

Victor Urzola

Designation:

Co-Founder & CEO

Headquarters:

Boulder, CO

Website:

rmihealth.com

Rocky Mountain Institute (RMI) is an independent, nonpartisan nonprofit organization focused on transforming global energy systems through market-driven clean energy solutions. Founded in 1982, RMI works with businesses, policymakers, communities, and investors to accelerate clean energy adoption, reduce energy waste, and improve energy access. Active in over 60 countries, the organization promotes a resilient, sustainable, and economically strong energy future.

Company:

SMSbiotech

Management:

Abdulkader Rahmo

Designation:

Co-Founder, President & CEO

Headquarters:

San Marcos, CA

Website:

smsbiotech.com

SMSbiotech is a San Diego based biotechnology company focused on advancing regenerative medicine through a novel human stem cell platform. The company develops therapies designed to support the body's natural healing processes and address the underlying causes of disease and tissue damage. Its patented, ethically sourced technology aims to improve treatment outcomes, expand therapeutic possibilities, and reduce overall healthcare costs.